ERBB2 and breast cancer: A comprehensive gene expression profiling study analyzing 40 datasets comprising 4,467 breast cancer cases found that younger age at diagnosis was associated with a higher frequency of HER2-positive and TNBC subtypes compared to Luminal subtypes, with TNBC carrying the poorest prognosis [17].